Home 
Reports Life Sciences Content
next article
16.01.2013
It started with a 44-year-old woman with solitary fibrous tumor, a rare cancer seen in only a few hundred people each year.
By looking at the entire DNA from this one patient's tumor, researchers have found a genetic anomaly that provides an important clue to improving how this cancer is diagnosed and treated.
Researchers at the University of Michigan Comprehensive Cancer Center sequenced the tumor's genome through a new program called MI-ONCOSEQ, which is designed to identify genetic mutations in tumors that might be targeted with new therapies being tested in clinical trials.
The sequencing also allows researchers to find new mutations. In this case, an unusual occurrence of two genes - NAB2 and STAT6 - fusing together. This is the first time this gene fusion has been identified.
"In most cases, mutations are identified because we see them happening again and again. Here, we had only one case of this. We knew NAB2-STAT6 was important because integrated sequencing ruled out all the known cancer genes. That allowed us to focus on what had been changed," says lead study author Dan R. Robinson, research fellow with the Michigan Center for Translational Pathology.
Once they found the aberration, the researchers looked at 51 other tumor samples from benign and cancerous solitary fibrous tumors, looking for the NAB2-STAT6 gene fusion. It showed up in every one of the samples. Results are published online in Nature Genetics.
"Genetic sequencing is extremely important with rare tumors," says study co-author Scott Schuetze, M.D., associate professor of internal medicine at the U-M Medical School. "Models of rare cancers to study in the laboratory are either not available or very limited. The sequencing helps us to learn more about the disease that we can use to develop better treatments or to help diagnose the cancer in others."
The NAB2-STAT6 fusion may prove to be a difficult target for therapies, but researchers believe they may be able to attack the growth signaling cycle that leads to this gene fusion.
"Understanding the changes induced in the cell by the NAB2-STAT6 gene fusion will help us to select novel drugs to study in patients with advanced solitary fibrous tumors. Currently this is a disease for which there are no good drug therapies available and patients are in great need of better treatments," Schuetze says.
No treatments or clinical trials are currently available based on these findings. Additional testing in the lab is needed to assess the best way to target NAB2-STAT6. The gene fusion could also potentially be used to help identify solitary fibrous tumors in cases where diagnosis is challenging.
Additional authors: Yi-Mi Wu; Shanker Kalyana-Sundaram; Xuhong Cao; Robert J. Lonigro; Yun-Shao Sung; Rui Wang; Fengyun Su; Matthew K. Iyer; Sameek Roychowdhury; Javed Siddiqui; Kenneth J. Pienta; Lakshmi P. Kunju; Moshe Talpaz; and Arul M. Chinnaiyan from U-M; Chun-Liang Chen; Lei Zhang; Samuel Singer; and Cristina R. Antonescu from Memorial Sloan-Kettering Cancer Center; Juan Miguel Mosquera from Weill Cornell Medical College.
Funding: National Cancer Institute grants: U01 CA111275, 5 P30 CA46592, P01 CA047179-15A2, and P50 CA140146-01; National Functional Genomics Center grant W81XWH-11-1-0520; U.S. Department of Defense; the Linn Fund, Cycle for Survival, the Alan Rosenthal Research Fund for Research in Sarcoma, the Weinstein Solitary Fibrous Tumor Research Fund, Doris Duke Charitable Foundation, Burroughs Wellcome Foundation, American Cancer Society, A. Alfred Taubman Institute at the University of Michigan.
Disclosure: The University of Michigan has filed for patent protection on the NAB2-STAT6 gene fusion and is currently looking for licensing partners to help bring the technology to market.
Reference: Nature Genetics, published online Jan. 13, 2013, DOI: 10.1038/ng.2509
Written by Nicole Fawcett
Nicole Fawcett | Source: EurekAlert!
Further information: www.umich.edu
next article
Overview of the latest five Focus news of the innovations-report:
In the focus: ChemCam follows the ?Yellowknife Road? to Martian wet area
Researchers have tracked a trail of minerals that point to the prior presence of water at the Curiosity rover site on Mars.
Instrument confirms presence of gypsum and related minerals
Researchers from Los Alamos National Laboratory and the French Space Agency have tracked a trail of minerals that point to the prior presence of water at the Curiosity rover site on Mars.
Researchers from the Mars Science Laboratory?s ChemCam team today described how ...
In the focus: Global warming may have severe consequences for rare Haleakal? silverswords
While the iconic Haleakal? silversword plant made a strong recovery from early 20th-century threats, it has now entered a period of substantial climate-related decline. New research published this week warns that global warming may have severe consequences for the silversword in its native habitat.
Known for its striking rosette, the silversword grows for 20-90 years before the single reproductive event at the end of its life, at which time it produces a large (up to six feet tall) inflorescence with as many as 600 flower heads.
The plant was in jeopardy in the early 1900s ...
In the focus: Lack of Protein Sp2 Disrupts Neuron Creation in Brain
A protein known as Sp2 is key to the proper creation of neurons from stem cells, according to researchers at North Carolina State University. Understanding how this protein works could enable scientists to ?program? stem cells for regeneration, which has implications for neural therapies.
Troy Ghashghaei and Jon Horowitz, both faculty in NC State?s Department of Molecular Biomedical Sciences and researchers in the Center for Comparative Medicine and Translational Research, wanted to know more about the function of Sp2, a cell cycle regulator that helps control how cells divide.
Previous research from Horowitz had ...
In the focus: Building Electronics From the Ground Up
There?s hardly a moment in modern life that doesn?t involve electronic devices, whether they?re guiding you to a destination by GPS or deciding which incoming messages merit a beep, ring or vibration.
But our expectation that the next shopping season will inevitably offer an upgrade to more-powerful gadgets largely depends on size ? namely, the ability of the industry to shrink transistors so that more can fit on ever-tinier chip surfaces.
Engineers have been up to the task of electronics miniaturization for decades ...
In the focus: New Sunspots Producing Space Weather
On Jan. 13, 2013, at 2:24 a.m. EST, the sun erupted with an Earth-directed coronal mass ejection or CME. Not to be confused with a solar flare, a CME is a solar phenomenon that can send solar particles into space and reach Earth one to three days later.
Experimental NASA research models, based on observations from the Solar Terrestrial Relations Observatory (STEREO) and the ESA/NASA mission the Solar and Heliospheric Observatory, show that the CME left the sun at speeds of 275 miles per second. This is a fairly typical speed for CMEs, though much slower than the ...
limp bizkit stations of the cross nike foamposite galaxy bill maher seabiscuit dingo nba all star weekend
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন